| Product Code: ETC7637131 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Peripheral Neuropathy Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Peripheral Neuropathy Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Peripheral Neuropathy Market - Industry Life Cycle |
3.4 Ireland Peripheral Neuropathy Market - Porter's Five Forces |
3.5 Ireland Peripheral Neuropathy Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.6 Ireland Peripheral Neuropathy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
3.7 Ireland Peripheral Neuropathy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Ireland Peripheral Neuropathy Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Ireland Peripheral Neuropathy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Peripheral Neuropathy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Ireland, a leading cause of peripheral neuropathy |
4.2.2 Growing awareness and diagnosis rates of peripheral neuropathy in the country |
4.2.3 Technological advancements in healthcare leading to better treatment options for peripheral neuropathy patients |
4.3 Market Restraints |
4.3.1 High cost of peripheral neuropathy treatments and medications |
4.3.2 Limited access to specialized healthcare services for peripheral neuropathy patients in rural areas |
5 Ireland Peripheral Neuropathy Market Trends |
6 Ireland Peripheral Neuropathy Market, By Types |
6.1 Ireland Peripheral Neuropathy Market, By Treatment |
6.1.1 Overview and Analysis |
6.1.2 Ireland Peripheral Neuropathy Market Revenues & Volume, By Treatment, 2021- 2031F |
6.1.3 Ireland Peripheral Neuropathy Market Revenues & Volume, By Pain Relievers, 2021- 2031F |
6.1.4 Ireland Peripheral Neuropathy Market Revenues & Volume, By Anti-Seizure Medications, 2021- 2031F |
6.1.5 Ireland Peripheral Neuropathy Market Revenues & Volume, By Antidepressants, 2021- 2031F |
6.1.6 Ireland Peripheral Neuropathy Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Peripheral Neuropathy Market, By Therapy Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Peripheral Neuropathy Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (TENS), 2021- 2031F |
6.2.3 Ireland Peripheral Neuropathy Market Revenues & Volume, By Physical Therapy, 2021- 2031F |
6.2.4 Ireland Peripheral Neuropathy Market Revenues & Volume, By Immunoglobulins, 2021- 2031F |
6.2.5 Ireland Peripheral Neuropathy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Peripheral Neuropathy Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Ireland Peripheral Neuropathy Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Ireland Peripheral Neuropathy Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Ireland Peripheral Neuropathy Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Peripheral Neuropathy Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Ireland Peripheral Neuropathy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Ireland Peripheral Neuropathy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Ireland Peripheral Neuropathy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5 Ireland Peripheral Neuropathy Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Peripheral Neuropathy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Ireland Peripheral Neuropathy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Ireland Peripheral Neuropathy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Ireland Peripheral Neuropathy Market Import-Export Trade Statistics |
7.1 Ireland Peripheral Neuropathy Market Export to Major Countries |
7.2 Ireland Peripheral Neuropathy Market Imports from Major Countries |
8 Ireland Peripheral Neuropathy Market Key Performance Indicators |
8.1 Number of new cases diagnosed with peripheral neuropathy annually |
8.2 Average time from symptom onset to diagnosis for peripheral neuropathy patients |
8.3 Patient satisfaction with available treatment options and healthcare services |
9 Ireland Peripheral Neuropathy Market - Opportunity Assessment |
9.1 Ireland Peripheral Neuropathy Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.2 Ireland Peripheral Neuropathy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
9.3 Ireland Peripheral Neuropathy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Ireland Peripheral Neuropathy Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Ireland Peripheral Neuropathy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Peripheral Neuropathy Market - Competitive Landscape |
10.1 Ireland Peripheral Neuropathy Market Revenue Share, By Companies, 2024 |
10.2 Ireland Peripheral Neuropathy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here